Citations

Clear

4801 citation(s) found for "Yu, Jennifer".

Utilization of Antitumor Necrosis Factor Biologics in Very Early Onset Inflammatory Bowel Disease
Kerur, Basavaraj , Fiedler, Karoline , Stahl, Marisa G. , Hyams, Jeffrey S. , Stephens, Michael C., Lu, Ying , Pfefferkorn, Marian, Alkhouri, Raza, Strople, Jennifer , Kelsen, Judith R. , Siebold, Leah, Goyal, Alka , Rosh, Joel R. , LeLeiko, Neal S. , Limbergen, Johan Van , Maltz, Ross , Karam, Lina , Heyman, Melvin B. , Benkov, Keith , Noe, Joshua D. , Moulton, Dedrick E., Pappa, Helen, Galanko, Joseph A. , Muise, Aleixo M. , Stephens, Michael, Leleiko, Neal S , Guerrerio, Anthony L. , Crowley, Eileen , Griffiths, Anne Marie , Deneau, Mark , Snapper, Scott B. , Kappelman, Michael D. , Benchimol, Eric I.

Mayo Clinic

Journal of Pediatric Gastroenterology and Nutrition | May 27, 2022 | Volume: 75 | Issue: 1 | Pages: 64-69

10.1097/mpg.0000000000003464 | PMID 35622080 Get It

Background:Research on the utilization and effectiveness of antitumor necrosis factor (TNF) biologics in children with very early onset inflammatory bowel disease (VEOIBD) is urgently needed. Here we describe anti‐TNF use and durability in a multicenter cohort.Methods:We performed a retrospective cohort study of patients diagnosed with VEOIBD (<6 years) between 2008 and 2013 at 25 North American centers. We performed chart abstraction at diagnosis and 1, 3, and 5 years after diagnosis. We examined the rate of initiation and durability of infliximab and adalimumab and evaluated associations between treatment durability and the following covariates with multivariate Cox proportional hazard regression: age at diagnosis, sex, disease duration, disease classification, and presence of combined immunomodulatory treatment versus monotherapy.Results:Of 294 children with VEOIBD, 120 initiated treatment with anti‐TNF therapy and 101 had follow‐up data recorded [50% Crohn disease (CD), 31% ulcerative colitis (UC), and 19% IBD unclassified (IBD‐U)]. The cumulative probability of anti‐TNF treatment was 15% at 1 year, 30% at 3 years, and 45% at 5 years from diagnosis; 56 (55%) were treated between 0 and 6 years old. Anti‐TNF durability was 90% at 1 year, 75% at 3 years, and 55% at 5 years. The most common reason for discontinuation of anti‐TNF were loss of response in 24 (57%) children. Children with UC/IBD‐U had lower durability than those with CD (hazard ratio [HR] 0.17; 95% confidence interval [CI], 0.06–0.51; P = 0.001).Conclusions:Utilization and durability of anti‐TNF in VEOIBD is relatively high and comparable with older children. Having Crohn disease (compared with UC/IBD‐U) is associated with greater durability.
The COVID-19 pandemic and sleep medicine: a look back and a look ahead
Khosla, Seema, Berneking, Michael , Cheung, Joseph , Epstein, Lawrence J., Meyer, Brittany, Ramar, Kannan , So, Jennifer Y. , Sullivan, Shannon, Wolfe, Lisa F. , Gurubhagavatula, Indira , Cheung, Joseph , Beam, Elena

Mayo Clinic

Journal of Clinical Sleep Medicine | May 27, 2022 | Volume: 18 | Issue: 8 | Pages: 2045-2050

10.5664/jcsm.10102 | PMID 35621129 Get It

Twice as nice: Cytomegalovirus tele‐education
Garson, Jennifer T. , Bernard, Stacy A. , Deziel, Paul J. , Lemke, Adley , Rivera, Christina G. , Razonable, Raymund R. , Lemke, Adley I, Razonable, Raymund R , Rivera, Christina G

Mayo Clinic

Transplant Infectious Disease | May 25, 2022 | Volume: 24 | Issue: 4 | Pages: No page available

10.1111/tid.13865 | PMID 35612090 Get It

Comparative Performance of Different Respiratory Test Parameters for Detection of Early Respiratory Insufficiency in Patients With ALS
Kelly, Cecilia R. , Parra‐Cantu, Carolina , Thapa, Prabin , Boynton, Bradley, Selim, Bernardo J., Sorenson, Eric J. , Martinez‐Thompson, Jennifer M. , Mandrekar, Jaywant, Staff, Nathan P. , Staff, Nathan P

Mayo Clinic

Neurology | May 23, 2022 | Volume: 99 | Issue: 7 | Pages: No page available

10.1212/wnl.0000000000200758 | PMID 35584920 Get It

Automated detection of low ejection fraction from a one-lead electrocardiogram: application of an AI algorithm to an electrocardiogram-enabled Digital Stethoscope
Attia, Zachi I. , Dugan, Jennifer , Rideout, Adam, Venkatraman, Subramaniam, Guo, Ling, Noseworthy, Peter A. , Pellikka, Patricia A. , Pham, Steve L, Friedman, Paul A. , Noseworthy, Peter A , Pellikka, Patricia A , Kapa, Suraj , Lopez-Jimenez, Francisco , Attia, Zachi I , Dugan, Jennifer , Maidens, John , Pham, Steve, Kapa, Suraj , López-Jiménez, Francisco

Mayo Clinic

European Heart Journal - Digital Health | May 23, 2022 | Volume: 3 | Issue: 3 | Pages: 373-379

10.1093/ehjdh/ztac030 | PMID 36712160 Get It

Abstract Aims Electrocardiogram (ECG)-enabled stethoscope (ECG-Scope) acquires a single-lead ECGs during cardiac auscultation and may facilitate real-time screening for pathologies not routinely identified by cardiac auscultation alone. We previously demonstrated an artificial intelligence (AI) algorithm can identify left ventricular dysfunction (LVSD) [defined as ejection fraction (EF) ≤ 40%] with an area under the curve (AUC) of 0.91 using a 12-lead ECG. Methods and results One hundred patients referred for clinically indicated echocardiography were prospectively recruited. ECG-Scope recordings with the patient supine and sitting were obtained in multiple electrode locations at the time of the echocardiogram. The AI algorithm for the detection of LVSD was retrained using single leads from ECG-12 and validated against ECG-Scope to determine accuracy for low EF detection (≤35%, &lt;40%, or &lt;50%). We evaluated the algorithm with respect to body position and lead location. Amongst 100 patients (aged 61.3 ± 13.8; 61% male, BMI: 30.0 ± 5.4), eight had EF≤40%, and six had EF 40–50%. The best single recording position was V2 with the patient supine [AUC: 0.88 (CI: 0.80–0.97) for EF≤35%, 0.85 (CI: 0.75–0.95) for EF≤40%, and 0.81 (CI: 0.71–0.90) for EF &lt; 50%]. When using an AI model to select the recording automatically, AUC was 0.91 (CI: 0.84–0.97) for EF≤35%, 0.89 (CI: 0.83–0.96) for EF≤40%, and 0.84 (CI: 0.73–0.94) for EF &lt; 50%. Conclusion An AI algorithm applied to an ECG-enabled stethoscope recording in standard auscultation positions reliably detected the presence of a low EF in this prospective study of patients referred for echocardiography. The ability to screen patients with a possible low EF during routine physical examination may facilitate rapid detection of LVSD.
Sodium‐glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation
Lemke, Adley , Brokmeier, Hannah M., Leung, Sarah B., Mara, Kristin C. , Wadei, Hani M. , Hill, Jennifer M. , Stegall, Mark D. , Kudva, Yogish C. , Shah, Pankaj, Kukla, Aleksandra , Mour, Girish K., Stegall, Mark D , Kudva, Yogish C. , Kukla, Aleksandra , Mara, Kristin C , Lemke, Adley I , Wadei, Hani M , Mour, Girish , Shah, Pankaj

Mayo Clinic

Clinical Transplantation | May 20, 2022 | Volume: 36 | Issue: 8 | Pages: No page available

10.1111/ctr.14718 | PMID 35593882 Get It

Abstract Introduction Diabetes mellitus in kidney transplant recipients is a risk factor for cardiovascular events and premature death. Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) are increasingly used in nontransplant populations to improve diabetes control and cardiovascular and renal benefits. Limited literature exists regarding the safety and efficacy of these agents in renal transplant recipients. Methods We retrospectively reviewed all kidney transplant recipients within our health system who were prescribed a SGLT2i after transplantation for diabetes. The safety, tolerability, and effectiveness of SGLT2i were analyzed. Results Thirty‐nine kidney transplant recipients were initiated on SGLT2i therapy, twenty‐seven of which remained on therapy for at least 1 year. Ten (25%) patients experienced an adverse event while on a SGLT2i, with urinary tract infections (UTI) being the most common. Seventeen patients (43%) discontinued the SGLT2i at the time of chart review, most commonly due to cost and kidney function decline. The median [IQR] hemoglobin A1c (HbA1c) at SGLT2i initiation of 8.4% [7.8–9.2] decreased to 7.5% [6.8–8.0%] after 3 months and 7.5% [6.5–7.9] after 12 months. No meaningful change in kidney function or tacrolimus exposure was observed. Conclusion SGLT2i may be a safe and effective treatment for diabetes in kidney transplant recipients. Cost is a barrier to SGLT2i therapy, and UTIs were the most frequently encountered adverse events in this cohort. More studies are needed to understand the safety profile and determine the effect of SGLT2i on diabetes‐related comorbidities among kidney transplant recipients.
Prevalence of co‐occurring serious illness diagnoses and association with health care utilization at the end of life
Nothelle, Stephanie , Jacobson, Debra J., Green, Ariel R. , Boyd, Cynthia M. , Rocca, Walter A. , Fan, Chun , Jacobson, Debra, Green, Ariel R , Nothelle, Stephanie , Chamberlain, Alanna M. , Sauver, Jennifer L. St.

Mayo Clinic

Journal of the American Geriatrics Society | May 20, 2022 | Volume: 70 | Issue: 9 | Pages: 2621-2629

10.1111/jgs.17881 | PMID 35593458 Get It

Abstract Introduction End‐of‐life care differs by serious illness diagnosis. Cancer and dementia are serious illnesses that have been associated with less intensive end‐of‐life health care use. It is not known how health care utilization varies in the presence of >1 serious illness. Methods We used the Rochester Epidemiology Project to identify persons living in a midwestern area who died on July 1, 2017–June 30, 2018 at age ≥65 years, and were seriously ill. We examined the number of emergency department (ED), hospital, and intensive care unit (ICU) stays in the last 6 months and the last 30 days of life. We used Poisson regression to determine the incidence rate ratio for ED, hospital, and ICU stay in the last 6 months and 30 days of life by number of serious illness diagnoses. For cancer and dementia, we examined the effect of an additional serious illness. Results We included a population of 1372 adults who were, on average, 84 years, 52% female, and 96% white. Approximately 41% had multiple serious illnesses. Compared to older adults with 1 serious illness diagnosis, rates of hospitalization, and ICU stay for adults with 2 or ≥3 serious illness diagnoses were at least 1.5 times higher in the last 6 months and the last 30 days of life. Rates of ED visits were significantly higher for older adults with 2 or ≥3 serious illness diagnoses in the last 6 months of life, but only higher for those with ≥3 versus 1 serious illness diagnosis in the last 30 days of life. For both cancer and dementia, rates of ED visits, hospitalization and ICU stay were lower for the condition alone than when an additional serious illness diagnosis was present. Conclusion Having multiple serious illnesses increases the risk of health care utilization at the end of life.
Excessive Postural Tachycardia and Postural Orthostatic Tachycardia Syndrome in Youth: Associations With Distress, Impairment, Health Behaviors, and Medication Recommendations
Klaas, Kelsey , Segner, Sara, Owens, Michele Tsai , Fahrenkamp, Amy J., Geske, Jennifer R. , Hofschulte, Deanna R., Farrell, Michael , Harbeck‐Weber, Cynthia , Biggs, Bridget K. , Klaas, Kelsey M , Fischer, Philip R. , Geske, Jennifer, Hofschulte, Deanna, HARBECK-WEBER, CYNTHIA, Biggs, Bridget K , Geske, Jennifer , Harbeck‐Weber, Cynthia

Mayo Clinic

Journal of Child Neurology | May 19, 2022 | Volume: 37 | Issue: 7 | Pages: 599-608

10.1177/08830738221078410 | PMID 35585700 Get It

Among adolescents with fatigue and postural dizziness, it is unclear how health behaviors and emotional distress relate to the presence of excessive postural tachycardia. We prospectively evaluated adolescents aged 13-22 years presenting with symptoms suggestive of autonomic dysfunction between September 2017 and December 2018. Patients underwent standard 10-minute, 70-degree head-up tilt testing. Clinician diagnoses and recommendations were recorded from the medical record. Patients completed validated self-report measures of lifestyle factors, autonomic symptoms, depression, anxiety, and functional disability. Of 179 patients, 58 were diagnosed with postural orthostatic tachycardia syndrome and 59 had excessive postural tachycardia, with 90.5% concordance between the 2 groups. Presence of excessive postural tachycardia was associated with greater baseline fluid intake and likelihood of medication prescription in their treatment plan. Medication findings were replicated for postural orthostatic tachycardia syndrome diagnosis. Presence of excessive postural tachycardia or postural orthostatic tachycardia syndrome did not differentiate patients on perceived symptom severity, emotional distress, disability, or health behaviors but did appear to determine treatment recommendations.
An investigation of metabolic disturbances, including urinary stone disease, hypothyroidism, and osteoporosis in basal cell nevus syndrome
Schlaht, Karl M. , Sas, David J. , Davis, Dawn Marie R. , Hand, Jennifer L. , Davis, Dawn M R

Mayo Clinic

Pediatric Dermatology | May 16, 2022 | Volume: 39 | Issue: 5 | Pages: 713-717

10.1111/pde.15022 | PMID 35574616 Get It

AbstractBackground/ObjectivesBasal cell nevus syndrome (BCNS) is an autosomal dominant skin cancer predisposition syndrome associated with abnormal mineral metabolism, a risk factor for urinary stone disease (USD). However, no research investigating the association between BCNS and USD or other manifestations of abnormal mineral metabolism has been conducted. The objective of this study is to investigate the association between BCNS and conditions associated with disordered mineral metabolism including USD, hypothyroidism, and osteoporosis and compare them to prevalence in the general population to elucidate potential unknown manifestations of the condition.MethodsThis retrospective study examined medical records of adult and pediatric patients with confirmed BCNS from the Mayo Clinic database from 1 January 1995 to 12 January 2020. Records were surveyed for evidence of USD and other comorbidities potentially related to BCNS. The studied cohort included 100 adult patients and 5 pediatric patients.ResultsA total of 105 patients were included in this analysis, 10 of whom experienced confirmed USD, representing a prevalence of 10%. Six adult patients were identified with a diagnosis of osteoporosis, representing a prevalence of 6%. Thirteen adult patients were identified with a diagnosis of hypothyroidism, representing a prevalence of 13%.ConclusionsThis study identified a prevalence of USD in BCNS patients comparable to estimates of national prevalence, indicating that known abnormalities in mineral metabolism likely do not increase the incidence of USD in BCNS patients. Additional findings included increased prevalence of hypothyroidism and decreased prevalence of osteoporosis in the BCNS cohort compared to national averages.